Gilead Sciences Inc

NASDAQ: GILD
$67.03
+$0.08 (+0.1%)
Closing price April 23, 2024
Gilead Sciences Inc is a leading biopharmaceutical company focused on developing and commercializing innovative medicines for life-threatening illnesses worldwide. With a strong emphasis on HIV/AIDS, COVID-19, viral hepatitis, and oncology, Gilead offers a range of treatments that address unmet medical needs. Notable products include Biktarvy, Veklury, and Yescarta. Founded in 1987 and based in Foster City, California, Gilead also engages in significant partnerships to advance its research and development efforts.
Wednesday's top analyst upgrades and downgrades included Apollo Global Management, Asana, Block, Caesars Entertainment, Dollar General, Gilead Sciences, Goldman Sachs, Invitation Homes, Medtronic,...
One big advantage to buying beaten-down stocks with substantial dividends is that one is paid to wait for the recovery. These six well-known stocks have been hammered but look like solid ideas for...
These seven top stocks may be somewhat off the radar, but the companies have a reasonably strong moat around their businesses, generous dividends and stocks with outstanding entry points now. 
Friday's top analyst upgrades and downgrades included AppLovin, BioCryst Pharmaceuticals, Boeing, CF Industries, Coupa Software, Crocs, Dutch Bros, DigitalOcean, Gilead Sciences, IBM, International...
The tech-heavy Nasdaq is firmly in bear market territory. Yet, its highest-yielding stocks have solid defensive qualities and are offering patient investors some of the best entry points in years and...
Monday's top analyst upgrades and downgrades included Amazon.com, Apple, Caterpillar, Comcast, Comerica, Gilead Sciences, Intel, Lululemon Athletica and McDonald's.
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Danaher, DoorDash, Freeport-McMoRan, Gap, Gilead Sciences, Huntington Bancshares, Independence Realty Trust, Intuitive...
History shows that placing bets on sector laggards has paid off handsomely for investors, according to a new research report. These eight diverse underperforming stocks also come with healthy and...
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
While income and growth investors may not look to the Nasdaq for total return, there are some gems in the index that make sense for investors now. The five highest-yielding Nasdaq stocks now offer...
These six Goldman Sachs stock picks offer a blend of high dividend yield and strong forecast dividend growth, making them ideal for income and growth investors worried about inflation and the very...
Here are a few big biopharma names on which Wall Street is growing more bearish.
Monday afternoon's top analyst upgrades and downgrades included American Electric, BP, Dollar Tree, Gilead, Lockheed Martin and more.
Thursday's premarket winners and losers included Meta Platforms, PayPal, Spotify, T-Mobile and Twitter.
Friday afternoon's top analyst upgrades and downgrades included Apple, Gilead, Goldman Sachs, Kroger, Raymond James, and more.